Urinary system neoplasm
MONDO:0021066A benign or malignant, primary or metastatic neoplasm involving the urinary system. --2003
Also known as: neoplasm of renal system, neoplasm of the urinary system, neoplasm of the urinary tract, neoplasm of urinary system, neoplasm of urinary tract, renal system neoplasm, renal system neoplasm (disease), renal system tumor
2992 clinical trials for this condition and its sub-types, 21 tagged with Urinary system neoplasm itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Urinary system neoplasm
-
Malignant urinary system neoplasm 75 trials · 1,664 incl. sub-types
10 sub-types
- Kidney cancer 244 trials · 851 incl. sub-types Sub-types →
- Urothelial carcinoma 363 trials · 692 incl. sub-types Sub-types →
- Urinary bladder cancer 39 trials · 682 incl. sub-types Sub-types →
- Infiltrating urothelial carcinoma 5 trials · 185 incl. sub-types Sub-types →
- Ureter cancer 27 trials · 34 incl. sub-types Sub-types →
- Urethra cancer 18 trials · 29 incl. sub-types Sub-types →
- Multiple endocrine neoplasia type 2B 2 trials
- Malignant prostate phyllodes tumor 0 trials
- Pheochromocytoma/paraganglioma syndrome 2 0 trials
- Pheochromocytoma/paraganglioma syndrome 5 0 trials
-
Kidney neoplasm 59 trials · 860 incl. sub-types
8 sub-types
- Kidney cancer 244 trials · 851 incl. sub-types Sub-types →
- Childhood kidney neoplasm 1 trial · 30 incl. sub-types Sub-types →
- Renal pelvis neoplasm 1 trial · 24 incl. sub-types Sub-types →
- Kidney benign neoplasm 4 trials · 12 incl. sub-types Sub-types →
- Mesonephric neoplasm 1 trial · 3 incl. sub-types Sub-types →
- Kidney hemangiopericytoma 0 trials
- Mixed epithelial stromal tumor of the kidney 0 trials Sub-types →
- Multiloculated renal cyst 0 trials
-
Urinary bladder neoplasm 65 trials · 699 incl. sub-types
6 sub-types
- Urinary bladder cancer 39 trials · 682 incl. sub-types Sub-types →
- Bladder flat intraepithelial lesion 0 trials · 30 incl. sub-types Sub-types →
- Bladder papillary urothelial neoplasm 1 trial · 13 incl. sub-types Sub-types →
- Bladder benign neoplasm 0 trials Sub-types →
- Bladder inflammatory myofibroblastic tumor 0 trials
- Urinary bladder villous adenoma 0 trials
-
Urothelial neoplasm 2 trials · 693 incl. sub-types
5 sub-types
- Urothelial carcinoma 363 trials · 692 incl. sub-types Sub-types →
- Infiltrating urothelial carcinoma 5 trials · 185 incl. sub-types Sub-types →
- Papillary urothelial neoplasm 0 trials · 13 incl. sub-types Sub-types →
- Urinary tract non-invasive transitional cell neoplasm 1 trial · 2 incl. sub-types Sub-types →
- Urothelial dysplasia 0 trials
-
Benign urinary system neoplasm 50 trials · 62 incl. sub-types
6 sub-types
- Kidney benign neoplasm 4 trials · 12 incl. sub-types Sub-types →
- Ureter benign neoplasm 1 trial Sub-types →
- Benign prostate phyllodes tumor 0 trials
- Benign urethral neoplasm 0 trials Sub-types →
- Bladder benign neoplasm 0 trials Sub-types →
- Urothelial papilloma 0 trials Sub-types →
-
Ureter neoplasm 2 trials · 34 incl. sub-types
3 sub-types
- Ureter cancer 27 trials · 34 incl. sub-types Sub-types →
- Ureter benign neoplasm 1 trial Sub-types →
- Polyp of ureter 0 trials
-
Urethra neoplasm 3 trials · 31 incl. sub-types
3 sub-types
- Urethra cancer 18 trials · 29 incl. sub-types Sub-types →
- Benign urethral neoplasm 0 trials Sub-types →
- Urethral villous adenoma 0 trials
-
Prostate phyllodes tumor 0 trials
2 sub-types
- Benign prostate phyllodes tumor 0 trials
- Malignant prostate phyllodes tumor 0 trials
Most studied deeper sub-types
-
New drug BL-B01D1 targets Hard-to-Treat solid tumors in early trial
Disease control Recruiting nowThis Phase II trial is testing a drug called BL-B01D1 in 76 adults with advanced urinary system or other solid tumors that have not responded to standard treatments. The study aims to find the best dose and see how well the drug shrinks tumors, while also monitoring safety and si…
Phase 2 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New combo aims to shrink penile cancer before surgery
Disease control Recruiting nowThis phase 2 trial tests whether giving pembrolizumab (Keytruda) plus chemotherapy (carboplatin and paclitaxel) before surgery can completely eliminate advanced penile cancer in the penis and lymph nodes. About 27 men with resectable, node-positive penile cancer will receive the …
Phase 2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New hope for kidney cancer: Real-World study tests vorolanib as Second-Line therapy
Disease control Recruiting nowThis study looks at how well the drug vorolanib works for people with advanced kidney cancer that cannot be removed by surgery or has spread. It is for patients who need a second treatment after their first one stopped working. The study will track how long the cancer stays under…
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
One drop, many cancers? a rapid test aims to spot cancer signals in blood, urine, or saliva
Diagnosis Recruiting nowThis study evaluates a rapid test called Methylscape that measures DNA methylation patterns in body fluids like blood, urine, or saliva. The goal is to see if it can detect a cancer signal and even predict where the cancer started, using a single sample. Researchers will compare …
Sponsor: Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo • Aim: Diagnosis
Last updated Aug 05, 2026 00:00 UTC
-
New PET scan agent could spot kidney cancer more accurately
Diagnosis Recruiting nowThis study tests a new radioactive imaging agent called [18F]RCCB6 for PET/CT scans to see if it can better detect kidney cancer, especially the most common type, clear cell renal cell carcinoma. Researchers will enroll 300 adults with confirmed or suspected kidney cancer. The go…
Phase 2 • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Opioid-Free anesthesia: a safer way to go under the knife?
Symptom relief Recruiting nowThis study compares opioid-free anesthesia to standard opioid-based anesthesia in 600 adults undergoing urological abdominal surgery. The goal is to see if avoiding opioids during surgery reduces the need for painkillers afterward and lowers side effects like nausea. Patients wil…
Sponsor: Jagiellonian University • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
Bright idea: light and occupational therapy may beat cancer fatigue
Symptom relief Recruiting nowThis study tests whether light therapy and occupational therapy can reduce fatigue in people with genitourinary cancers (like prostate, kidney, or bladder cancer). About 224 adults on active cancer treatment will be assigned to receive light therapy, occupational therapy, both, o…
Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Can AI outthink cancer experts? a landmark trial pits five AIs against tumor boards
Knowledge-focused Recruiting nowThis trial asks whether five advanced AI models can match the treatment recommendations of expert tumor boards for cancer patients. Using 100 standardized synthetic cases across breast, lung, urological, digestive, and gynecological cancers, each AI and two independent tumor boar…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Aug 02, 2026 00:00 UTC
-
Could spinal anesthesia cut bleeding risk in prostate surgery?
Knowledge-focused Recruiting nowThis study compares spinal anesthesia to general anesthesia in men undergoing open simple prostatectomy for an enlarged prostate. The goal is to see if spinal anesthesia leads to less postoperative bleeding, such as fewer blood transfusions or less need for bladder irrigation. Ei…
Sponsor: Hitit University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Sweat sensor may predict blood pressure danger in elderly cancer surgery
Knowledge-focused Recruiting nowThis study is testing whether measuring skin conductance—a sign of nervous system activity—can predict dangerous drops in blood pressure after spinal anesthesia in elderly cancer patients. Researchers will monitor 102 patients aged 65 and older undergoing urologic cancer surgery.…
Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC